New cream aims to soothe rash caused by cancer drugs
Symptom relief
Terminated
This study tested a cream called ATR-04 to see if it could safely reduce the facial rash caused by certain cancer drugs (EGFR inhibitors). About 60 adults with cancer who were about to start these drugs were planned to join. The study was withdrawn before any participants enrolle…
Phase: PHASE1, PHASE2 • Sponsor: Azitra Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 07:53 UTC